These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35388438)
1. Successful Rituximab Therapy for Pediatric Antiphospholipid-Related Chorea: A Case Report and Review of the Literature. D'hont A; De Wachter M; Driesen Y; Sabato V; Joos R; Ceulemans B Neuropediatrics; 2022 Oct; 53(5):366-369. PubMed ID: 35388438 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review]. Pons I; Espinosa G; Cervera R Med Clin (Barc); 2015 Feb; 144(3):97-104. PubMed ID: 24698717 [TBL] [Abstract][Full Text] [Related]
3. Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. Kiechl-Kohlendorfer U; Ellemunter H; Kiechl S Neuropediatrics; 1999 Apr; 30(2):96-8. PubMed ID: 10401693 [TBL] [Abstract][Full Text] [Related]
4. Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea. Brogna C; Mariotti P; Manna R Lupus; 2014 Dec; 23(14):1449-51. PubMed ID: 25237169 [No Abstract] [Full Text] [Related]
5. Narrowing the window for 'senile chorea': a case with primary antiphospholipid syndrome. Gelosa G; Tremolizzo L; Galbussera A; Perego R; Capra M; Frigo M; Apale P; Ferrarese C; Appollonio I J Neurol Sci; 2009 Sep; 284(1-2):211-3. PubMed ID: 19467547 [TBL] [Abstract][Full Text] [Related]
6. [Case report; Chorea as the first manifestation of systemic lupus erythematosus associated with anti-phospholipid syndrome]. Sasaki H; Ito K; Furusaki A; Amasaki Y; Abe T Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):744-6. PubMed ID: 24796148 [No Abstract] [Full Text] [Related]
7. Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment. Diószegi Á; Tarr T; Nagy-Vincze M; Nánásy-Vass M; Veisz R; Bidiga L; Dezső B; Balla J; Szodoray P; Szekanecz Z; Soltész P Lupus; 2018 Aug; 27(9):1552-1558. PubMed ID: 29635999 [TBL] [Abstract][Full Text] [Related]
9. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome. Sayar Z; Burke S; Mittal P; Cohen H Lupus; 2022 Oct; 31(12):1485-1490. PubMed ID: 36074077 [TBL] [Abstract][Full Text] [Related]
12. [Chorea and primary antiphospholipid syndrome]. van Heereveld HA; van den Hoogen FH; de Vaan G; Blok WL; de Coo IF; Boerbooms AM Ned Tijdschr Geneeskd; 1992 Sep; 136(39):1917-9. PubMed ID: 1407167 [TBL] [Abstract][Full Text] [Related]
13. Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus treated with rituximab: case report and a review of the literature. Sukara G; Baresic M; Sentic M; Brcic L; Anic B Acta Reumatol Port; 2015; 40(2):169-75. PubMed ID: 25782914 [TBL] [Abstract][Full Text] [Related]
14. Rituximab in thrombotic primary antiphospholipid syndrome: a pilot study from a single centre in China. You Y; Shi C; Zhou Z; Wang F; Sun Y; Teng J; Liu H; Cheng X; Su Y; Shi H; Yang C; Ye J Ann Rheum Dis; 2021 Jun; 80(6):820-822. PubMed ID: 33452001 [No Abstract] [Full Text] [Related]
15. Reversible dementia and chorea in a young woman with the lupus anticoagulant. Van Horn G; Arnett FC; Dimachkie MM Neurology; 1996 Jun; 46(6):1599-603. PubMed ID: 8649556 [TBL] [Abstract][Full Text] [Related]
16. Aortitis in the setting of catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus. González-García A; López-Rodríguez M; Redondo S; Patier JL; Masso P; Tenorio M; Fajardo GS; Sarhane Y; Lacalzada MM; Manzano L Lupus; 2020 Aug; 29(9):1126-1129. PubMed ID: 32517572 [TBL] [Abstract][Full Text] [Related]
17. Severe antiphospholipid antibody syndrome - response to plasmapheresis and rituximab. Gkogkolou P; Ehrchen J; Goerge T J Dermatolog Treat; 2017 Sep; 28(6):564-566. PubMed ID: 28084106 [TBL] [Abstract][Full Text] [Related]